Iakovlev et al. demonstrated that, for CA9 quantification in multiple cervical tumor biopsies per patient, the highest variation was inter-tumor, followed by intra-tumor and intra-tumor section variation. The gene discussed is CA9; the disease is uterine cervix neoplasm.